Emily Adland
Postdoctoral Scientist
I began working in Philip Goulder's research group in 2009 as a research assistant. I subsequently undertook a DPhil within the group which I completed in 2016. My current research interests centre around mechanisms of non-progressing paediatric HIV infection with a focus on the epidemic in sub-Saharan Africa.
Recent publications
-
A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells.
Journal article
Sampson O. et al, (2022), J Immunol Methods, 504
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
Journal article
Frater J. et al, (2021), Lancet HIV, 8, e474 - e485
-
Natural and vaccine-induced antibody and cellular responses against emerging SARS-CoV-2 variants of concern
Journal article
Skelly DT. et al, (2021)
-
Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa.
Journal article
Jooste P. et al, (2016), J Clin Virol, 85, 71 - 74
-
Human Parvovirus 4 Infection among Mothers and Children in South Africa
Internet publication
Matthews PC. et al, (2015), 21, 713 - 715